648423-85-2 Usage
Uses
Used in Pharmaceutical Industry:
Imidazo[1,2-a]pyridine-7-carboxylic acid (9CI) is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications, particularly in the treatment of cancer and inflammatory diseases.
Used in Agrochemical Industry:
In the agrochemical sector, Imidazo[1,2-a]pyridine-7-carboxylic acid (9CI) serves as a vital component in the creation of novel agrochemicals. Its incorporation into these products can lead to the development of more effective and targeted pest control solutions, enhancing crop protection and yield.
Used in Medicinal Chemistry Research:
Imidazo[1,2-a]pyridine-7-carboxylic acid (9CI) is utilized as a valuable compound in medicinal chemistry research. Its exploration for biological activities, such as anti-cancer and anti-inflammatory properties, contributes to the advancement of drug discovery and the identification of new therapeutic agents.
Used in Organic Synthesis:
As an important intermediate in organic synthesis, Imidazo[1,2-a]pyridine-7-carboxylic acid (9CI) is employed in the preparation of a wide range of organic compounds. Its versatility in chemical reactions enables the synthesis of diverse molecules with potential applications in various fields, including materials science, chemical biology, and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 648423-85-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,8,4,2 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 648423-85:
(8*6)+(7*4)+(6*8)+(5*4)+(4*2)+(3*3)+(2*8)+(1*5)=182
182 % 10 = 2
So 648423-85-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H6N2O2/c11-8(12)6-1-3-10-4-2-9-7(10)5-6/h1-5H,(H,11,12)
648423-85-2Relevant academic research and scientific papers
NEW 2-AMIDOTHIADIAZOLE DERIVATIVES
-
Page/Page column 54, (2010/04/30)
New 2-amidothiadiazole derivatives having the chemical structure of formula (I) or pharmaceutically acceptable salts or N-oxides thereof as agonists of S1P1 receptors.
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
-
Page/Page column 105-106, (2009/05/30)
The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R1, q, A, B, X1, X2, X3, X4, X5 and R2 are as defined herein, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
-
Page/Page column 101; 102, (2009/05/30)
The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R1, A, X1, X2, X3, X4, X5 and R2 are as defined herein, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
N-PHENYL-(2R,5S)DIMETHYLPIPERADINE DERIVATIVE
-
Page/Page column 18, (2010/02/12)
The present invention relates to a novel N-phenyl-(2R,5S)dimethylpiperazine derivatives useful as antiandrogenic agent which exhibits a sufficient prostate gland reducing effect as compared with conventional compounds and are excellent in oral activity. The compound of the present application is useful in preventing or treating prostate cancer, benign prostatic hyperplasia, and the like. The present invention also provides a novel intermediate useful in producing the compound of the present invention.
